Department of General and Gastroenterological Surgery, Osaka Medical College, 2-7, Daigaku-machi, Takatsuki, Osaka, 569-8686, Japan.
Translational Research Program, Osaka Medical College, 2-7, Daigaku-machi, Takatsuki, Osaka, 569-8686, Japan.
Surg Today. 2020 Apr;50(4):413-418. doi: 10.1007/s00595-019-01902-w. Epub 2019 Oct 31.
Patients who undergo pancreatectomy for pancreatic ductal adenocarcinoma (PDA) develop relatively early recurrence, but pulmonary metastasis from PDA is rare. Between January 2008 and December 2016, a total of 120 consecutive patients underwent pancreatectomy for primary PDA at Osaka Medical College Hospital. Among these, 13 patients developed pulmonary metastasis and 6 patients underwent pulmonary metastasectomy. Among these patients, the median disease-free survival following initial pancreatic surgery was 26.1 months, and the median overall survival (OS) interval was 39 months. On the other hand, seven patients did not undergo pulmonary resection. The median OS interval of these patients was 33 months. The 1-, 3-, and 5-year OS rates were 100%, 80%, and 60%, respectively, for patients who underwent pulmonary metastasectomy and 100.0%, 42.8%, and 0%, respectively, for those who did not undergo the procedure. Our experience has shown that surgical resection may lengthen the survival time of patients who tolerate surgery.
对于接受胰腺导管腺癌(PDA)胰切除术的患者,会相对较早地出现复发,但 PDA 的肺转移较为罕见。2008 年 1 月至 2016 年 12 月,共有 120 例原发性 PDA 患者在大阪医科大学医院接受了胰切除术。其中,13 例患者发生了肺转移,6 例患者接受了肺转移切除术。这些患者中,初始胰腺手术后无疾病生存的中位数为 26.1 个月,总生存(OS)间隔的中位数为 39 个月。另一方面,7 例患者未进行肺切除术。这些患者的中位 OS 间隔为 33 个月。接受肺转移切除术的患者 1、3、5 年 OS 率分别为 100%、80%和 60%,而未接受该手术的患者分别为 100.0%、42.8%和 0%。我们的经验表明,手术切除可能会延长能够耐受手术的患者的生存时间。